Weekly Dose of Optimism #194
Not Boring2350 字 (约 10 分钟)
72
Eli Lilly's novel triple-hormone agonist retatrutide shows near-surgical weight loss effects in obesity treatment, signaling a major breakthrough in next-gen weight-loss drugs.
入选理由：患者使用 12mg retatrutide 80 周平均减重 28.3%，相当于 70 磅
FeaturedArticle#Biotech#Weight Loss Drugs#Clinical Trials#Eli Lilly#GLP-1英文